The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The vaccine advisory panel for the Food and Drug Administration (FDA) on Thursday voted to recommend matching the composition ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

Once adopted by the FDA and Centers for Disease Control and Prevention, the change could effectively end use of the original ...

Future COVID-19 vaccines and boosters should be bivalent – meaning they’ll target older strains of the virus as well as the newer omicron BA.4 and BA.5 variants – following a unanimous recommendation ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

U.S. health officials will present a new vaccine plan that recommends an annual COVID-19 booster and proposes changes to the ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

The CDC and FDA announced on Friday that their surveillance system flagged a possible link between the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over ...

Jan 14, 2023 -- A vaccine database found a possible link between the Pfizer/BioNTech bivalent COVID-19 vaccine and ischemic strokes in people over 65 who got the shot, the CDC and the FDA said in ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...